Inventor
Maurizio Pellecchia
Inventor
San Diego, CA, US
Overview
Patents· 20 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations19%
G01NInvestigating or analysing materials by determining their chemical or physical properties19%
A61KPreparations for medical, dental or toiletry purposes13%
C07DHeterocyclic compounds13%
C07CAcyclic or carbocyclic compounds10%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms9%
Y10TTechnical subjects covered by former us classification7%
C07KPeptides3%
C07BGeneral methods of organic chemistry1%
G01RMeasuring electric variables1%
PatentTitleYear
11,008,325Inhibitors of cancer invasion, attachment, and/or metastasis20219,266,828'Inhibitors of Furin and other pro-protein convertases'20169,115,061'Naphthalene-based inhibitors of anti-apoptotic proteins'20158,937,193'Apogossypolone derivatives as anticancer agents'20158,487,131'Optically pure apogossypol derivative as pan-active inhibitor of anti-apoptotic B-cell lymphoma/leukemia-2 (BCL-2)'20138,436,207'Naphthalene-based inhibitors of anti-apoptotic proteins'20138,431,529'Bi-dentate compounds as kinase inhibitors'20138,367,644'Methods and compounds useful to induce apoptosis in cancer cells'20138,039,668'Naphthalene-based inhibitors of anti-apoptotic proteins'20117,951,832'Pyrazole derivatives as kinase inhibitors'20117,947,717'Inhibitors of lethal factor protease'20117,812,058'Methods and compounds useful to induce apoptosis in cancer cells'20107,741,521'Inhibition of bid-induced cell-death using small organic molecules'20107,723,076'Use of selective labeling to detect and characterize molecular interactions by nuclear magnetic resonance spectroscopy'20107,718,680'Inhibition of lethal factor protease activity from anthrax toxin'20107,653,490'Nuclear magnetic resonance assembly of chemical entities'20107,252,931'NMR-solve method for rapid identification of bi-ligand drug candidates'20076,979,531'SEA-TROSY and related methods'20056,797,460'NMR-solve method for rapid identification of bi-ligand drug candidates'20046,620,589'NMR-solve method for rapid identification of Bi-ligand drug candidates'2003Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2003–2013Based in San Diego, CA, US· patent location history
2004–2007Patents assigned to TRIAD THERAPEUTICS INC (3)· patent assignee history
2010–2015Patents assigned to BURNHAM INST MEDICAL RESEARCH (6)· patent assignee history
2010–2013Patents assigned to BURNHAM INST (4)· patent assignee history
2011–2016Based in La Jolla, CA, US· patent location history
2013–2015Patents assigned to PELLECCHIA MAURIZIO (6)· patent assignee history
2013–2016Patents assigned to SANFORD BURNHAM MED RES INST (4)· patent assignee history
2021Based in Riverside, CA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BURNHAM INST MEDICAL RESEARCH | 6 | 2010–2015 |
| PELLECCHIA MAURIZIOself | 6 | 2013–2015 |
| BURNHAM INST | 4 | 2010–2013 |
| SANFORD BURNHAM MED RES INST | 4 | 2013–2016 |
| TRIAD THERAPEUTICS INC | 3 | 2004–2007 |
Locations
| Location | Patents | Span |
|---|---|---|
| San Diego, California, US | 14 | 2003–2013 |
| La Jolla, California, US | 5 | 2011–2016 |
| Riverside, California, US | 1 | 2021 |